The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer
Open accessAbstract
CD44 is a cell surface HA‐binding glycoprotein that is overexpressed to some extent by almost all tumors of epithelial origin and plays an important role in tumor initiation and metastasis. CD44 is a compelling marker for cancer stem cells of many solid malignancies. In addition, interaction of HA and CD44 promotes EGFR‐mediated pathways, consequently leading to tumor cell growth, tumor cell migration, and chemotherapy resistance in solid cancers. Accumulating evidence indicates that major HA‐CD44 signaling pathways involve a specific variant of CD44 isoforms; however, the particular variant almost certainly depends on the type of tumor cell and the stage of the cancer progression. Research to date suggests use of monoclonal antibodies against different CD44 variant isoforms and targeted inhibition of HA/CD44‐mediated signaling combined with conventional radio/chemotherapy may be the most favorable therapeutic strategy for future treatments of advanced stage malignancies. Thus, this paper briefly focuses on the association of the major CD44 variant isoforms in cancer progression, the role of HA‐CD44 interaction in oncogenic pathways, and strategies to target CD44‐overexpressed tumor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tan, J., Wang, X., Su, X., Li, H., Shi, Y., Wang, L., & Ren, G.-S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022836 · Cited by 72
RetractedGraphene: Status and Prospects
Geim, A. K. (2009) · Science · doi:10.1126/science.1158877 · Cited by 13,942
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., & Weiss, S. (2005) · Science · doi:10.1126/science.1104274 · Cited by 7,790
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
Gold Nanoparticles for Biology and Medicine
Giljohann, D. A., Seferos, D. S., Daniel, W. L., Massich, M. D., Patel, P. C., & Mirkin, C. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200904359 · Cited by 2,356
Prince, M. E., Sivanandan, R., Kaczorowski, A., Wolf, G. T., Kaplan, M. J., Dalerba, P., Weissman, I. L., Clarke, M. F., & Ailles, L. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610117104 · Cited by 2,164
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
Neuberger, T., Schöpf, B., Hofmann, H., Hofmann, M., & von Rechenberg, B. (2005) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2005.01.064 · Cited by 1,728
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Jin, L., Hope, K. J., Zhai, Q., Smadja-Joffe, F., & Dick, J. E. (2006) · Nature Medicine · doi:10.1038/nm1483 · Cited by 1,219
Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.038 · Cited by 1,192 · cited 1×
“Recently CD44v9 has emerged as a novel marker of cancer stemness in a variety of solid tumors including HNSCC [72–77].”
Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., & Bell, J. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12160 · Cited by 1,015
Electrochemical Tuning of Luminescent Carbon Nanodots: From Preparation to Luminescence Mechanism
Bao, L., Zhang, Z., Tian, Z., Zhang, L., Liu, C., Lin, Y., Qi, B., & Pang, D. (2011) · Advanced Materials · doi:10.1002/adma.201102866 · Cited by 1,014
Sheridan, C., Kishimoto, H., Fuchs, R. K., Mehrotra, S., Bhat-Nakshatri, P., Turner, C. H., Goulet, R., Badve, S., & Nakshatri, H. (2006) · Breast Cancer Research · doi:10.1186/bcr1610 · Cited by 993
Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties
Itano, N., Sawai, T., Yoshida, M., Lenas, P., Yamada, Y., Imagawa, M., Shinomura, T., Hamaguchi, M., Yoshida, Y., Ohnuki, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.25085 · Cited by 901
Misra, S., Hascall, V. C., Markwald, R. R., & Ghatak, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00201 · Cited by 830
Alkilany, A. M., Thompson, L. B., Boulos, S. P., Sisco, P. N., & Murphy, C. J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.005 · Cited by 807
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
Thorek, D. L. J., Chen, A. K., Czupryna, J., & Tsourkas, A. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-9002-7 · Cited by 772
Jordan, A., Scholz, R., Maier-Hauff, K., Johannsen, M., Wust, P., Nadobny, J., Schirra, H., Schmidt, H., Deger, S., Loening, S., et al. (2001) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(00)01239-7 · Cited by 731
Todaro, M., Gaggianesi, M., Catalano, V., Benfante, A., Iovino, F., Biffoni, M., Apuzzo, T., Sperduti, I., Volpe, S., Cocorullo, G., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.009 · Cited by 717
Brown, R. L., Reinke, L. M., Damerow, M. S., Perez, D., Chodosh, L. A., Yang, J., & Cheng, C. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44540 · Cited by 631
CD44 is of Functional Importance for Colorectal Cancer Stem Cells
Du, L., Wang, H., He, L., Zhang, J., Ni, B., Wang, X., Jin, H., Cahuzac, N., Mehrpour, M., Lu, Y., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1034 · Cited by 588
Understanding cancer stem cell heterogeneity and plasticity
Tang, D. G. (2012) · Cell Research · doi:10.1038/cr.2012.13 · Cited by 563
The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein research
Gottesman, M. M., & Ling, V. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.060 · Cited by 558
Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug Treatment
Perez-Tomas, R. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777585077 · Cited by 509
The structure and function of hyaluronan: An overview
LAURENT, T. C., LAURENT, U. B., & FRASER, J. R. E. (1996) · Immunology & Cell Biology · doi:10.1038/icb.1996.32 · Cited by 503
Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
Leung, E. L.-H., Fiscus, R. R., Tung, J. W., Tin, V. P.-C., Cheng, L. C., Sihoe, A. D.-L., Fink, L. M., Ma, Y., & Wong, M. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014062 · Cited by 473
Inorganic nanotubes and fullerene-like nanoparticles
Tenne, R. (2006) · Nature Nanotechnology · doi:10.1038/nnano.2006.62 · Cited by 462
Platt, V. M., & Szoka, F. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800024g · Cited by 456
Hyaluronan and its binding proteins, the hyaladherins
Toole, B. P. (1990) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(90)90081-o · Cited by 425
Bourguignon, L. Y. W., Singleton, P. A., Diedrich, F., Stern, R., & Gilad, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311838200 · Cited by 422
Pellegrino, T., Kudera, S., Liedl, T., Muñoz Javier, A., Manna, L., & Parak, W. J. (2005) · Small · doi:10.1002/smll.200400071 · Cited by 412
Hyaluronan Binding by Cell Surface CD44
Lesley, J., Hascall, V. C., Tammi, M., & Hyman, R. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61467-5 · Cited by 389
Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell
Yae, T., Tsuchihashi, K., Ishimoto, T., Motohara, T., Yoshikawa, M., Yoshida, G. J., Wada, T., Masuko, T., Mogushi, K., Tanaka, H., et al. (2012) · Nature Communications · doi:10.1038/ncomms1892 · Cited by 383
Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels
Lee, H., Mok, H., Lee, S., Oh, Y.-K., & Park, T. G. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.011 · Cited by 365
Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities
Toole, B. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0479 · Cited by 362
CD44 variant exon epitopes in primary breast cancer and length of survival
Kaufmann, M., von Minckwitz, G., Heider, K.-H., Ponta, H., Herrlich, P., & Sinn, H.-P. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90521-9 · Cited by 353
Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells
Krause, D. S., Lazarides, K., von Andrian, U. H., & Van Etten, R. A. (2006) · Nature Medicine · doi:10.1038/nm1489 · Cited by 349
PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo
Choi, K. Y., Min, K. H., Yoon, H. Y., Kim, K., Park, J. H., Kwon, I. C., Choi, K., & Jeong, S. Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.010 · Cited by 336
Eliaz, R. E., & Szoka, F. C. (2001) · PubMed · Cited by 330
Tijink, B. M., Buter, J., de Bree, R., Giaccone, G., Lang, M. S., Staab, A., Leemans, C. R., & van Dongen, G. A. M. S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0910 · Cited by 315
Bourguignon, L. Y. W. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.007 · Cited by 305
Cho, H.-J., Yoon, H. Y., Koo, H., Ko, S.-H., Shim, J.-S., Lee, J.-H., Kim, K., Chan Kwon, I., & Kim, D.-D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.028 · Cited by 304
Gupta, A. K., & Curtis, A. S. G. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.095 · Cited by 302
Poly(l-lysine)-Modified Iron Oxide Nanoparticles for Stem Cell Labeling
Babič, M., Horák, D., Trchová, M., Jendelová, P., Glogarová, K., Lesný, P., Herynek, V., Hájek, M., & Syková, E. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700410z · Cited by 291
Redox regulation in stem-like cancer cells by CD44 variant isoforms
Nagano, O., Okazaki, S., & Saya, H. (2013) · Oncogene · doi:10.1038/onc.2012.638 · Cited by 280
Cichy, J., & Puré, E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302098 · Cited by 277
Understanding the Dual Nature of CD44 in Breast Cancer Progression
Louderbough, J. M. V., & Schroeder, J. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0156 · Cited by 273
Tammi, R. H., Kultti, A., Kosma, V.-M., Pirinen, R., Auvinen, P., & Tammi, M. I. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.005 · Cited by 272
Hyaluronidases in cancer biology
Stern, R. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.017 · Cited by 261 · cited 2×
“In the enzymatic process, hyaluronidases (HAases or HYALs) are a class of enzymes that predominantly degrade HA, though they have limited ability to degrade chondroitin and chondroitin sulphates [78, 103].”
A Hyaluronic Acid−Taxol Antitumor Bioconjugate Targeted to Cancer Cells
Luo, Y., Ziebell, M. R., & Prestwich, G. D. (2000) · Biomacromolecules · doi:10.1021/bm000283n · Cited by 261
Kuhn, S., Koch, M., Nübel, T., Ladwein, M., Antolovic, D., Klingbeil, P., Hildebrand, D., Moldenhauer, G., Langbein, L., Franke, W. W., et al. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0384 · Cited by 252
The role of the CD44/ezrin complex in cancer metastasis
Martin, T. A., Harrison, G., Mansel, R. E., & Jiang, W. G. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00172-5 · Cited by 250
El-Boubbou, K., Zhu, D. C., Vasileiou, C., Borhan, B., Prosperi, D., Li, W., & Huang, X. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100455c · Cited by 250
Intravenous magnetic nanoparticle cancer hyperthermia
Hainfeld, J., & Huang (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s43770 · Cited by 245
Screaton, G. R., Bell, M. V., Bell, J. I., & Jackson, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31376-0 · Cited by 243
Hyaluronan as a therapeutic target in human diseases
Liang, J., Jiang, D., & Noble, P. W. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.017 · Cited by 230
Novel Nanomaterials for Clinical Neuroscience
Gilmore, J. L., Yi, X., Quan, L., & Kabanov, A. V. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9099-6 · Cited by 224
CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor
Stauder, R., Eisterer, W., Thaler, J., & Gunthert, U. (1995) · Blood · doi:10.1182/blood.v85.10.2885.bloodjournal85102885 · Cited by 221
Inhibition of tumor growthin vivo by hyaluronan oligomers
Zeng, C., Toole, B. P., Kinney, S. D., Kuo, J.-W., & Stamenkovic, I. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980729)77:3<396::aid-ijc15>3.0.co;2-6 · Cited by 215
Olsson, E., Honeth, G., Bendahl, P.-O., Saal, L. H., Gruvberger-Saal, S., Ringnér, M., Vallon-Christersson, J., Jönsson, G., Holm, K., Lövgren, K., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-418 · Cited by 204
Inorganic hollow nanoparticles and nanotubes in nanomedicine
Son, S. J., Bai, X., & Lee, S. B. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.002 · Cited by 200
Binding of hyaluronate to the surface of cultured cells.
Underhill, C. B., & Toole, B. P. (1979) · The Journal of cell biology · doi:10.1083/jcb.82.2.475 · Cited by 200
Yoshikawa, M., Tsuchihashi, K., Ishimoto, T., Yae, T., Motohara, T., Sugihara, E., Onishi, N., Masuko, T., Yoshizawa, K., Kawashiri, S., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3609-t · Cited by 191
Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance
Toole, B. P., & Slomiany, M. G. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.04.002 · Cited by 182
CD44 variant isoforms in head and neck squamous cell carcinoma progression
Wang, S. J., Wong, G., de Heer, A., Xia, W., & Bourguignon, L. Y. W. (2009) · The Laryngoscope · doi:10.1002/lary.20506 · Cited by 181
Lee, M.-Y., Yang, J.-A., Jung, H. S., Beack, S., Choi, J. E., Hur, W., Koo, H., Kim, K., Yoon, S. K., & Hahn, S. K. (2012) · ACS Nano · doi:10.1021/nn302538y · Cited by 175
HYAL1 Hyaluronidase in Prostate Cancer: A Tumor Promoter and Suppressor
Lokeshwar, V. B., Cerwinka, W. H., Isoyama, T., & Lokeshwar, B. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1022 · Cited by 171
Hyaluronic Acid Immobilized Magnetic Nanoparticles for Active Targeting and Imaging of Macrophages
Kamat, M., El-Boubbou, K., Zhu, D. C., Lansdell, T., Lu, X., Li, W., & Huang, X. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100354m · Cited by 170
Magnetic Nanoparticle-Based Hyperthermia for Head & Neck Cancer in Mouse Models
Zhao, Q., Wang, L., Cheng, R., Mao, L., Arnold, R. D., Howerth, E. W., Chen, Z. G., & Platt, S. (2012) · Theranostics · doi:10.7150/thno.3854 · Cited by 165
Brainson, C. F., & Kuperwasser, C. (2007) · Breast Cancer Research · doi:10.1186/bcr1673 · Cited by 163
Spicer, A. P., & Tien, J. (2004) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20006 · Cited by 158
Shen, H., Shi, S., Zhang, Z., Gong, T., & Sun, X. (2015) · Theranostics · doi:10.7150/thno.10804 · Cited by 158
TNF-α Induction of CD44-Mediated Leukocyte Adhesion by Sulfation
Maiti, A., Maki, G., & Johnson, P. (1998) · Science · doi:10.1126/science.282.5390.941 · Cited by 156
Gras, S. L., Günthert, U., Stauder, R., Curt, F., Oliferenko, S., Kluin‐Nelemans, H. C., Marie, J., Proctor, S., Jasmin, C., & Smadja‐Joffe, F. (1998) · Blood · doi:10.1182/blood.v91.9.3401 · Cited by 154
Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors
Franzmann, E. J., Schroeder, G. L., Goodwin, W. J., Weed, D. T., Fisher, P., & Lokeshwar, V. B. (2003) · International Journal of Cancer · doi:10.1002/ijc.11252 · Cited by 148
Wang, S. J., & Bourguignon, L. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.077 · Cited by 146
Slomiany, M. G., Grass, G. D., Robertson, A. D., Xiao, Y., Maria, B. L., Beeson, C. C., & Toole, B. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2491 · Cited by 144
Urakawa, H., Nishida, Y., Wasa, J., Arai, E., Zhuo, L., Kimata, K., Kozawa, E., Futamura, N., & Ishiguro, N. (2011) · International Journal of Cancer · doi:10.1002/ijc.26014 · Cited by 144
Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors
Rivkin, I., Cohen, K., Koffler, J. Y., Melikhov, D., Peer, D., & Margalit, R. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.067 · Cited by 144
Hyaluronan: Towards novel anti-cancer therapeutics
Karbownik, M. S., & Nowak, J. Z. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71465-8 · Cited by 142
CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence
Hirata, K., Suzuki, H., Imaeda, H., Matsuzaki, J., Tsugawa, H., Nagano, O., Asakura, K., Saya, H., & Hibi∥, T. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.314 · Cited by 139
Therapeutic applications of hyaluronan
Gaffney, J. J., Matou‐Nasri, S., Grau-Olivares, M., & SLEVIN, M. A. (2009) · Molecular BioSystems · doi:10.1039/b910552m · Cited by 136
El‐Dakdouki, M. H., Zhu, D. C., El‐Boubbou, K., Kamat, M. N., Chen, J., Li, W., & Huang, X. (2012) · Biomacromolecules · doi:10.1021/bm300046h · Cited by 129
The invasive front of carcinomas. The most important area for tumour prognosis?
Bryne, M., Boysen, M., Alfsen, G. C., Abeler, V. M., Sudbø, J., Nesland, J. M., Kristensen, G. B., Piffkò, J., & Bánkfalvi, Á. (1998) · PubMed · Cited by 127
Baumgartner, G., Gomar-Höss, C., Sakr, L., Ulsperger, E., & Wogritsch, C. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00204-3 · Cited by 123
Börjesson, P. K. E., Postema, E. J., Roos, J. C., Colnot, D. R., Marres, H. A. M., van Schie, M. H., Stehle, G., de Bree, R., Snow, G. B., Oyen, W. J. G., et al. (2003) · PubMed · Cited by 113
Wang, S. J., Wreesmann, V. B., & Bourguignon, L. (2007) · Head & Neck · doi:10.1002/hed.20544 · Cited by 102
Development of hyaluronic acid–Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides
Kumar, A. B., Sahoo, B., Montpetit, A. J., Behera, S., Lockey, R. F., & Mohapatra, S. S. (2007) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2007.03.001 · Cited by 99
Slomiany, M. G., Dai, L., Bomar, P. A., Knackstedt, T., Kranc, D. A., Tolliver, L. B., Maria, B. L., & Toole, B. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0143 · Cited by 99
Hyaluronan Oligosaccharides as a Potential Anticancer Therapeutic
Toole, B. P., Ghatak, S., & Misra, S. (2008) · Current Pharmaceutical Biotechnology · doi:10.2174/138920108785161569 · Cited by 98
Altered hyaluronan biosynthesis in cancer progression
Itano, N., & Kimata, K. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.006 · Cited by 98
Yamaguchi, A., Urano, T., Goi, T., Saito, M., Takeuchi, K., Hirose, K., Nakagawara, G., Shiku, H., & Furukawa, K. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1122 · Cited by 96
Hyaluronidase reduces human breast cancer xenografts in SCID mice
Shuster, S., Frost, G. I., Csoka, A. B., Formby, B., & Stern, R. (2002) · International Journal of Cancer · doi:10.1002/ijc.10668 · Cited by 95
Thomas, R. G., Moon, M. J., Lee, H., Sasikala, A. R. K., Kim, C. S., Park, I., & Jeong, Y. Y. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.06.010 · Cited by 89
Verel, I., Heider, K., Siegmund, M., Ostermann, E., Patzelt, E., Sproll, M., Snow, G. B., Adolf, G. R., & van Dongen, G. A. M. S. (2002) · International Journal of Cancer · doi:10.1002/ijc.10369 · Cited by 87
Hyaluronan and hyaluronidase in genitourinary tumors
Melanie, A. S. (2008) · Frontiers in bioscience · doi:10.2741/3108 · Cited by 86
Gilg, A. G., Tye, S. L., Tolliver, L. B., Wheeler, W. G., Visconti, R. P., Duncan, J. D., Kostova, F. V., Bolds, L. N., Toole, B. P., & Maria, B. L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1228 · Cited by 84
CD44 Expression Is Associated with Increased Survival in Node-Negative Invasive Breast Carcinoma
Diaz, L. K., Zhou, X., Wright, E. T., Cristofanilli, M., Smith, T., Yang, Y., Sneige, N., Şahin, A. A., & Gilcrease, M. Z. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2184 · Cited by 84
Croix, B. S., Man, S., & Kerbel, R. S. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00199-2 · Cited by 82
CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.
Rall, C., & Rustgi, A. K. (1995) · PubMed · Cited by 82
Hosono, K., Nishida, Y., Knudson, W., Knudson, C. B., Naruse, T., Suzuki, Y., & Ishiguro, N. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060828 · Cited by 82
Akima, K., Ito, H., Iwata, Y., et al. (1996) · Journal of drug targeting · doi:10.3109/10611869609046255 · Cited by 78
CD44 Glycoproteins in Colorectal Cancer: Expression, Function, and Prognostic Value
Wielenga, V. T., van der Neut, R., Offerhaus, G. J. A., & Pals, S. T. (1999) · Advances in cancer research · doi:10.1016/s0065-230x(08)60787-3 · Cited by 77
Pandey, M. S., Harris, E. N., Weigel, J. A., & Weigel, P. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800886200 · Cited by 77
CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
Li, Z., Chen, K., Jiang, P., Zhang, X., Li, X., & Li, Z. (2014) · Diagnostic Pathology · doi:10.1186/1746-1596-9-79 · Cited by 77
Bourguignon, L., Singleton, P. A., & Diedrich, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403608200 · Cited by 76
Bachar, G. Y., Cohen, K., Hod, R., Feinmesser, R., Mizrachi, A., Shpitzer, T., Katz, O., & Peer, D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.040 · Cited by 73
Gansauge, F., Gansauge, S., Zobywalski, A., Scharnweber, C., Link, K. H., Nussler, A. K., & Beger, H. G. (1995) · PubMed · Cited by 72
Colnot, D. R., Roos, J. C., de Bree, R., Wilhelm, A. J., Kummer, J. A., Hanft, G., Heider, K., Stehle, G., Snow, G. B., & van Dongen, G. A. M. S. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0396-5 · Cited by 72
Ween, M. P., Hummitzsch, K., Rodgers, R. J., Oehler, M. K., & Ricciardelli, C. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9363-7 · Cited by 69
Involvement of hyaluronidases in colorectal cancer
Bouga, H., Tsouros, I., Bounias, D., Kyriakopoulou, D., Stavropoulos, M., Papageorgakopoulou, N., Theocharis, D. A., & Vynios, D. H. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-499 · Cited by 67
Pammer, J., Weninger, W., Mildner, M., Burian, M., Wojta, J., & Tschachler, E. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(1998100)186:2<157::aid-path169>3.0.co;2-m · Cited by 65
Torre, C. A., Wang, S. J., Xia, W., & Bourguignon, L. (2010) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archoto.2010.25 · Cited by 63
Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors
Pillay, V., Frank, D., Tyagi, C., Tomar, L. K., Choonara, Y. E., du Toit, L. C., Kumar, P., & Penny, C. B. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s50941 · Cited by 62
Prognostic significance of CD44 variant 2 upregulation in colorectal cancer
Ozawa, M., Ichikawa, Y., Zheng, Y.-W., Oshima, T., Miyata, H., Nakazawa, K., Guan, H.-B., Shiozawa, M., Akaike, M., Watanabe, K., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.253 · Cited by 61
Sauter, A., Kloft, C., Gronau, S., Bogeschdorfer, F., Erhardt, T., Golze, W., Schroen, C., Staab, A., Riechelmann, H., & Hoermann, K. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.4.927 · Cited by 59
CD44 Targeting Magnetic Glyconanoparticles for Atherosclerotic Plaque Imaging
El‐Dakdouki, M. H., El‐Boubbou, K., Kamat, M. N., Huang, R., Abela, G. S., Kiupel, M., Zhu, D. C., & Huang, X. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1021-8 · Cited by 59
Expression of CD44 Variants and Its Association with Survival in Pancreatic Cancer
Gotoda, T., Matsumura, Y., Kondo, H. G., Saitoh, D., Shimada, Y., Kosuge, T., Kanai, Y., & Kakizoe, T. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00493.x · Cited by 58
Different CD44 splicing patterns define prognostic subgroups in multiple myeloma
Stauder, R., van Driel, M., Schwärzler, C., Thaler, J., Lokhorst, H. M., Kreuser, E., Bloem, A. C., Günthert, U., & Eisterer, W. (1996) · Blood · doi:10.1182/blood.v88.8.3101.bloodjournal8883101 · Cited by 53
Toxicity issues in cancer drug development.
Gewirtz, D. A., Bristol, M. L., & Yalowich, J. C. (2010) · PubMed · Cited by 52
Hyaluronidase is more elevated in human brain metastases than in primary brain tumours.
Delpech, B., Laquerrière, A., Maingonnat, C., Bertrand, P., & Fréger, P. (2002) · PubMed · Cited by 52
Characterization of CD44v3 containing isoforms in head and neck cancer
Reategui, E. P., de Mayolo, A. A., Das, P. M., Astor, F. C., Singal, R., Hamilton, K. L., Goodwin, W. J., Carraway, K. L., & Franzmann, E. J. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.9.3065 · Cited by 50
Kuniyasu, H., Oue, N., Tsutsumi, M., Tahara, E., & Yasui, W. (2001) · PubMed · Cited by 48
Prognostic Value of CD44 Variant exon 6 Expression in Non-Small Cell Lung Cancer: a Meta-analysis
Zhao, S., He, J., Qiu, Z.-X., Chen, N.-Y., Luo, Z., Chen, B., & Li, W. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.16.6761 · Cited by 43
Magnetic microparticulate carriers with immobilized selective ligands in DNA diagnostics
Horák, D., Rittich, B., Španová, A., & Beneš, M. J. (2004) · Polymer · doi:10.1016/j.polymer.2004.11.049 · Cited by 43
El‐Dakdouki, M. H., El‐Boubbou, K., Zhu, D. C., & Huang, X. (2011) · RSC Advances · doi:10.1039/c1ra00737h · Cited by 42
Clinical Significance of CD44 Variants Expression in Colorectal Cancer
Li, X., Ji, M. Q., Wu, J., Jiang, J., & Wu, C. (2013) · Tumori Journal · doi:10.1177/030089161309900115 · Cited by 31
Aso, T., Matsuo, M., Kiyohara, H., Taguchi, K., Rikimaru, F., Shimokawa, M., Segawa, Y., Higaki, Y., Umeno, H., Nakashima, T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116596 · Cited by 28
Pancreatic cancer cells express CD44 variant 9 and multidrug resistance protein 1 during mitosis
Kiuchi, S., Ikeshita, S., Miyatake, Y., & Kasahara, M. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.12.001 · Cited by 26
The role of CD44v3 expression in female breast carcinomas.
Ryś, J., Kruczak, A., Lackowska, B., Jaszcz-Gruchała, A., Brandys, A., Stelmach, A., & Reinfuss, M. (2003) · PubMed · Cited by 25
Zalewski, B. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i4.583 · Cited by 23
Eissa, S., Shehata, H. H., Mansour, A., Esmat, M. E., & El-Ahmady, O. (2012) · Medical Oncology · doi:10.1007/s12032-012-0295-8 · Cited by 19
de Sá, V. K., Olivieri, E. H. R., Parra, E. R., Ab’Saber, A. M., Takagaki, T. Y., Soares, F. A., Carraro, D. M., Carvalho, L., & Capelozzi, V. L. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.06.010 · Cited by 18
Cited by
CD44: A Multifunctional Mediator of Cancer Progression
Hassn Mesrati, M., Syafruddin, S. E., Mohtar, M. A., & Syahir, A. (2021) · Biomolecules · doi:10.3390/biom11121850 · Cited by 492
The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11
Liu, T., Jiang, L., Tavana, O., & Gu, W. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3037 · Cited by 490
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
Usman, S., Waseem, N. H., Nguyen, T. K. N., Mohsin, S., Jamal, A., Teh, M.-T., & Waseem, A. (2021) · Cancers · doi:10.3390/cancers13194985 · Cited by 430
Cancer stem cell surface markers on normal stem cells
Kim, W.-T., & Ryu, C. J. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.6.039 · Cited by 332
Aati, S., Farouk, H. O., Elkarmalawy, M. H., Aati, H. Y., Tolba, N. S., Hassan, H. M., Rateb, M. E., & Hamad, D. S. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111432 · Cited by 9
Metadata
- Authors
- Thapa, R., & Wilson, G. D.
- Venue
- Stem Cells International
- Publisher
- Wiley
- Published
- 2016-01
- Volume
- 2016
- Issue
- 1
- Pages
- 2087204-2087204
- ISSN
- 1687-966X (ISSN-L)
- 1687-9678
- OpenAlex
- W2339017415
- Cited by
- 312
- References
- 137
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.